Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/30/2012CA2826651A1 Substituted aromatic sulfur compounds and methods of their use
08/30/2012CA2825699A1 Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
08/30/2012CA2824497A1 Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
08/30/2012CA2824415A1 Benzamide derivatives as p2x7 receptor antagonists
08/30/2012CA2824350A1 (pyridin-4-yl)benzylamides as allosteric modulators of alpha 7 nachr
08/30/2012CA2820767A1 Asymmetric ureas and medical uses thereof
08/29/2012EP2492688A1 Molecular biomarkers for predicting response to antitumor treatment in lung cancer
08/29/2012EP2492285A1 Hydrazido derivatives of hyaluronic acid
08/29/2012EP2492282A1 Modulation of growth hormone receptor expression and insulin-like growth factor expression
08/29/2012EP2492270A2 Sod-imitating metal complexes
08/29/2012EP2492269A1 Aminothiazole derivative
08/29/2012EP2492268A1 Compounds having CRTH2 antagonist activity
08/29/2012EP2492267A1 Indole derivatives as CRTH2 receptor antagonists in combination with a second active ingredient
08/29/2012EP2492266A1 5-hydroxypyrimidine-4-carboxamide derivative
08/29/2012EP2492264A2 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same
08/29/2012EP2492263A1 Pyridizinone Derivatives
08/29/2012EP2492262A1 Fused heterocyclic compound and thrombopoietin receptor activator
08/29/2012EP2492261A1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer
08/29/2012EP2491951A1 Block copolymer for intraperitoneal administration containing anti-cancer agent, micelle preparation, and cancer therapeutic agent comprising the micelle preparation as active ingredient
08/29/2012EP2491934A1 Use of albiflorin for anti-depression
08/29/2012EP2491933A1 Pharmaceutical composition for oral administration
08/29/2012EP2491932A2 Use of biomarkers for monitoring the course of treatment of a pulmonary disease upon treatment with treprostinil
08/29/2012EP2491931A1 Transdermally absorbable donepezil-containing preparation
08/29/2012EP2491930A1 Pharmaceutical combination of betahistine and trimetazidine
08/29/2012EP2491929A1 Use of Nifuratel to treat infections caused by Clostridium species
08/29/2012EP2491928A2 Therapeutic agent for vitiligo and method of accelerating pigmentation
08/29/2012EP2491927A1 Use of a spirolide, analogues and derivatives for treating and/or preventing pathological conditions linked to the tau and beta-amyloid proteins
08/29/2012EP2491926A1 Treatment of protein degradation disorders
08/29/2012EP2491925A1 Antitumoral combination comprising cabazitaxel and cisplatin
08/29/2012EP2491924A1 Water-based paste containing diclofenac sodium
08/29/2012EP2491923A2 Combinations of therapeutic agents for treating cancer
08/29/2012EP2491922A1 Immediate-release tablet formulations of a thrombin receptor antagonist
08/29/2012EP2491921A1 Conservation of anhydrous form of gemifloxacin
08/29/2012EP2491920A1 Effervescent tablet, sachet and dry syrup of gemifloxacin
08/29/2012EP2491919A1 Pharmaceutical solution of taxanes comprising ph regulator and preparation method thereof
08/29/2012EP2491800A1 Improved stability in vitamin and mineral supplements
08/29/2012EP2491785A1 Method and compositions for treating HIV infections
08/29/2012EP2491145A1 Methods and compositions for cell-proliferation-related disorders
08/29/2012EP2491123A2 Single molecule nucleic acid nanoparticles
08/29/2012EP2491050A2 Glycoside derivative and uses thereof
08/29/2012EP2491045A1 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
08/29/2012EP2491043A2 2,7-substituted thieno[3,2-d]pyrimidine compounds as protein kinase inhibitors
08/29/2012EP2491042A1 Solid forms of n-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide
08/29/2012EP2491041A2 Bivalent diazo bicyclic smac mimetics and the uses thereof
08/29/2012EP2491040A2 Method of preparing sitagliptin and intermediates used therein
08/29/2012EP2491039A1 Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors
08/29/2012EP2491038A1 Disubstituted octahy - dropyrrolo [3,4-c]pyrroles as orexin receptor modulators
08/29/2012EP2491037A1 Compounds
08/29/2012EP2491036A2 Pyrazolopyrimidine derivatives
08/29/2012EP2491035A1 Derivatives of purine or deazapurine useful for the treatment of (inter alia) viral infections
08/29/2012EP2491034A1 Fused heterocyclic compounds as orexin receptor modulators
08/29/2012EP2491033A2 Azaindazoles to treat flaviviridae virus infection
08/29/2012EP2491032A1 Akt inhibitors
08/29/2012EP2491031A1 Fused heterocyclic compounds as orexin receptor modulators
08/29/2012EP2491029A1 Glycoside derivatives and uses thereof
08/29/2012EP2491028A1 Indazole and pyrazolopyridine compounds as ccr1 receptor antagonists
08/29/2012EP2491027A1 Salts of imatinib with tartaric acids
08/29/2012EP2491026A1 Novel heteroaryl imidazoles and heteroaryl triazoles as gamma-secretase modulators
08/29/2012EP2491025A1 Azaazulene compounds
08/29/2012EP2491024A1 Substituted n-phenyl-1-(4-pyridinyl)-1h-pyrazol-3-amines
08/29/2012EP2491023A2 Coumarin compounds as receptor modulators with therapeutic utility
08/29/2012EP2491022A1 Diazepam derivatives as modulators of chemokine receptors
08/29/2012EP2491021A1 Novel acylpiperazinones and their use as pharmaceuticals
08/29/2012EP2491017A1 Alpha adrenergic receptor modulators
08/29/2012EP2491016A1 Substituted benzosulphonamides
08/29/2012EP2491015A1 Substituted benzosulphonamides
08/29/2012EP2491014A1 Substituted halophenoxybenzamide derivatives
08/29/2012EP2491009A1 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use
08/29/2012EP2491007A1 Inhibitors of the microsomal prostaglandin e2 synthase-1
08/29/2012EP2491005A1 Use of 4-[ethyl(dimethyl)ammonio]butanoate in the treatment of cardiovascular disease
08/29/2012EP2490767A1 Rna antagonists targeting gli2 for the treatment of leukemia
08/29/2012EP2490722A2 Modulation of gel temperature of poloxamer-containing formulations
08/29/2012EP2490715A1 Novel dosing regimen and method of treatment
08/29/2012EP2490711A1 A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
08/29/2012EP2490704A2 Therapeutic composition
08/29/2012EP2490700A2 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
08/29/2012EP2490699A1 Oral delivery of therapeutically effective lna oligonucleotides
08/29/2012EP2490697A1 Method and formulation for the control of parasites
08/29/2012EP2490696A1 Methods and pharmaceutical compositions for the treatment of disorders of glucose homeostasis
08/29/2012EP2490695A1 Method of preventing type 1 diabetes
08/29/2012EP2490694A2 Methods and systems for pharmacogenomic treatment of cardiovascular conditions
08/29/2012EP2490693A1 PYRAZOLO [3,4-b]PYRIDIN-4-ONE KINASE INHIBITORS
08/29/2012EP2490692A1 Quinolinone-pyrazolone m1 receptor positive allosteric modulators
08/29/2012EP2490691A1 Use of 1h-quinazoline-2,4-diones
08/29/2012EP2490690A1 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
08/29/2012EP2490689A2 Injectable formulations for intra- articular or peri-articular administration
08/29/2012EP2490688A1 Combination cancer therapy with hsp90 inhibitory compounds
08/29/2012EP2490687A1 Compositions for treatment of cystic fibrosis and other chronic diseases
08/29/2012EP2490686A1 The new application of 2-pyrrolidone derivatives
08/29/2012EP2490685A1 Causal therapy of diseases or conditions associated with cns or pns demyelination
08/29/2012EP2490684A2 Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
08/29/2012EP2490683A2 Method for treating herpes virus infection
08/29/2012EP2490682A1 Derivatives of n-hydroxybenzamide for treating hiv infections
08/29/2012EP2490681A2 The pharmaceutical composition in dry powder form for inhalation
08/29/2012EP2490680A2 Neuroprotection and myelin repair using nestorone®
08/29/2012EP2490679A2 Methods of making and using compositions comprising flavonoids
08/29/2012EP2490678A1 Coated capsules and tablets of a fatty acid oil mixture
08/29/2012EP2490676A2 Pharmaceutical compositions of pde-5 inhibitors and dapoxetine
08/29/2012EP2490675A1 Pharmaceutical compositions of sevelamer
08/29/2012EP2490673A2 Amorphous rotigotine co-precipitates
1 ... 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 ... 7860